Sopharma Overview

  • Year Founded
  • 1933

Year Founded

  • Status
  • Public

  • Employees
  • 6,049

Employees

  • Stock Symbol
  • SFA

Stock Symbol

  • Investments
  • 35

  • Share Price
  • $3.31
  • (As of Tuesday Closing)

Sopharma General Information

Description

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 16 Iliensko Shosse Street
  • Sofia, 1220
  • Bulgaria
+359 02
Primary Industry
Distributors/Wholesale
Other Industries
Pharmaceuticals
Stock Exchange
XBUL
Corporate Office
  • 16 Iliensko Shosse Street
  • Sofia, 1220
  • Bulgaria
+359 02

Sopharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sopharma Stock Performance

As of 17-Nov-2026, Sopharma’s stock price is $3.31. Its current market cap is $1.78B with 538M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.31 $3.37 $1.65 - $3.97 $1.78B 538M 58.9K $0.09

Sopharma Financials Summary

As of 30-Jun-2026, Sopharma has a trailing 12-month revenue of $1.63B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,499,655 1,413,933 1,453,683
Revenue 1,628,700 1,498,962 1,173,321 1,033,191
EBITDA 172,789 146,437 89,829 95,834
Net Income 94,037 74,183 42,054 52,878
Total Assets 1,234,493 1,243,075 951,996 851,552
Total Debt 327,131 367,125 254,842 197,316
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sopharma‘s full profile, request access.

Request a free trial

Sopharma Patents

Sopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240426794-A1 Methods of control and analysis of n-nitrosocytisine in cytisine samples Pending 15-Jun-2023
WO-2024259073-A2 Methods of control and analysis of n-nitrosocytisine in cytisine samples Inactive 15-Jun-2023
WO-2024259073-A3 Methods of control and analysis of n-nitrosocytisine in cytisine samples Inactive 15-Jun-2023
AU-2019440193-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Inactive 12-Apr-2019
CA-3126725-A1 Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies Active 12-Apr-2019 A61K31/439
To view Sopharma’s complete patent history, request access »

Sopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sopharma Investments & Acquisitions (35)

Sopharma’s most recent deal was a Merger/Acquisition with CESMA (Distributors (Healthcare)). The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CESMA (Distributors (Healthcare)) 01-Oct-2026 Merger/Acquisition Distributors (Healthcare)
Pharmanova 31-Jul-2025 Secondary Transaction - Private Pharmaceuticals
Sopharma (Portfolio of Pharmaceutical Product Based in Sofia, Bulgaria) 04-Oct-2024 Corporate Asset Purchase Buildings and Property
Pharmanova 28-Aug-2024 Merger/Acquisition Pharmaceuticals
Sopharma Group (Portfolio of two Pharmaceutical Products in Poland) 01-Dec-2023 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 35 investments and acquisitions. Get the full list »

Sopharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Sopharma’s complete esg history, request access »

Sopharma Exits (7)

Sopharma’s most recent exit was on 28-Dec-2020 from Briz. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Briz 28-Dec-2020 Completed
Aromania 21-Jul-2017 Completed
Briz 03-Dec-2013 Completed
Maritzatex 31-Jul-2013 Completed
Briz 10-Nov-2009 Merger/Acquisition Completed
You’re viewing 5 of 7 exits. Get the full list »

Sopharma Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Sopharma Trading Sofia, Bulgaria 2006
Pharmanova Belgrade, Serbia 1991
Biopharm Engineering Sliven, Bulgaria 1981
Vitaminy Uman, Ukraine 1953

Sopharma FAQs

  • When was Sopharma founded?

    Sopharma was founded in 1933.

  • Where is Sopharma headquartered?

    Sopharma is headquartered in Sofia, Bulgaria.

  • What is the size of Sopharma?

    Sopharma has 6,049 total employees.

  • What industry is Sopharma in?

    Sopharma’s primary industry is Distributors/Wholesale.

  • Is Sopharma a private or public company?

    Sopharma is a Public company.

  • What is Sopharma’s stock symbol?

    The ticker symbol for Sopharma is SFA.

  • What is the current stock price of Sopharma?

    As of 17-Nov-2026 the stock price of Sopharma is $3.31.

  • What is the current market cap of Sopharma?

    The current market capitalization of Sopharma is $1.78B.

  • What is Sopharma’s current revenue?

    The trailing twelve month revenue for Sopharma is $1.63B.

  • What is Sopharma’s annual earnings per share (EPS)?

    Sopharma’s EPS for 12 months was $0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process